|
| Status |
Public on Dec 22, 2021 |
| Title |
LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
35228570 |
| |
| Submission date |
Jul 06, 2021 |
| Last update date |
Mar 23, 2022 |
| Contact name |
Christopher Murray |
| Organization name |
Stanford University
|
| Department |
Genetics
|
| Lab |
Winslow
|
| Street address |
1291 Welch Rd. B261, Beckman Center
|
| City |
Stanford |
| State/province |
California |
| ZIP/Postal code |
94305 |
| Country |
USA |
| |
|
| Platforms (3) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (100)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE179497 |
LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer [Primary Tuba-seq] |
| GSE179499 |
LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer [Secondary Tuba-seq] |
| GSE179500 |
LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer [XTR Bulk RNA-seq] |
| GSE179501 |
LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer [scRNA-seq] |
| GSE179502 |
LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer [Sorted scRNA-seq] |
| GSE179558 |
LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer [C/EBP Bulk RNA-seq] |
|
| Relations |
| BioProject |
PRJNA744193 |
Less...
More...